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Inulin-type fructans (ITF) are nondigestible/fermentable carbohydrates which are able — through the modification of the gut microbiota — to counteract
high-fat (HF) diet-induced obesity, endotoxemia and related-metabolic alterations. However, their influence on adipose tissue metabolism has been poorly
studied until now. The aim of this study was to assess the influence of ITF supplementation on adipose tissue metabolism, by focusing on a G protein-coupled
receptor (GPR), GPR43, as a potential link between gut fermentation processes and white adipose tissue development. Male C57bl6/J mice were fed a standard
diet or an HF diet without or with ITF (0.2 g/day per mouse) during 4 weeks. The HF diet induced an accumulation of large adipocytes, promoted peroxisome
proliferator activated receptor gamma (PPARγ)-activated differentiation factors and led to a huge increase in GPR43 expression in the subcutaneous adipose
tissue. All those effects were blunted by ITF treatment, which modulated the gut microbiota in favor of bifidobacteria at the expense of Roseburia spp. and of
Clostridium cluster XIVa. The dietary modulation of GPR43 expression seems independent of endotoxemia, in view of data obtained in vivo (acute and
chronic lipopolysaccharides treatment). In conclusion, ITF, which promote gut fermentation, paradoxically counteract GPR43 overexpression induced in the
adipose tissue by an HF diet, a phenomenon that correlates with a beneficial effect on adiposity and with potential decrease in PPARγ-activated processes.
© 2010 Elsevier Inc. All rights reserved.Keywords: Gut microbiota; prebiotics; adipose tissue; high-fat feeding; GPR43; PPARγ1. Introduction
Obesity, which is characterized by an excess of fat mass, results
from interactions between genetic and environmental factors. It is
well known that a fat-enriched diet leads, especially in genetically
predisposed individuals, to an accumulation of adipose tissue and to
the development ofmetabolic alterations associated to weight gain. In
addition, an innovative hypothesis has recently been proposed
whereby another important aspect, the microbial ecology in humans,
could be an important factor affecting energy homeostasis [1–4].
Over the past 5 years, the implication of the gut microbiota in
energy homeostasis has been highlighted in several experimental☆ This project was supported a FNRS grant (n°1.5.095.09F).
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doi:10.1016/j.jnutbio.2010.05.009studies. Indeed, Backhed et al. showed that germ-free mice resist to
high-fat (HF) diet-induced obesity and that the conventionalization of
adult germ-free mice produces a rapid increase in body fat content
despite lower food intake [5,6]. Additionally, changes in gut
microbiota composition were shown in different mice models of
obesity, including ob/ob mice, and obese mice fed an HF-rich diet
[7–10]. Several molecular targets were proposed which may link
microbes-related events occurring in the colon with adipose tissue
development, such as the so-called fasting-induced adipose factor.
Conventionalization experiments showed that its intestinal expres-
sion is blunted after microbial colonization of the gut, thereby
allowing increased lipoprotein-lipase (LPL) dependent fat storage in
the adipose tissue [5]. Other molecular targets have been proposed
recently, among which G protein-coupled receptors (GPR) 41 and 43
which are activated by short chain fatty acids (SCFA) generated by
bacterial gut fermentation of nondigestible carbohydrates [11–13].
Among these two receptors, GPR43 — which is highly expressed in
adipocytes — seems to be implicated in adipose tissue metabolism.
Previous works showed that acetate and propionate inhibit isopro-
terenol-induced lipolysis in 3T3-L1 adipocytes [14] and also that the
2 E.M. Dewulf et al. / Journal of Nutritional Biochemistry xx (2010) xxx–xxxactivation of GPR43 by acetate in vivo results in reduced plasma levels
of free fatty acids, showing the inhibition of lipolysis [15]. These
effects are mediated through GPR43 activation since they are
abolished in GPR43-knockout animals [15]. In addition to the
potential implication of GPR43 in lipolysis, its expression is induced
in vitro in differentiating adipocytes. In fact, acetate and propionate
stimulate adipogenesis via GPR43, since blocking GPR43 expression in
3T3-L1 cells, using siRNA, inhibits differentiation as well as fat
accumulation in cells [14].
Given the important role of the gut microbial ecology in
association with obesity, several studies have focused on the
hypothesis that the onset of obesity may be influenced by targeted
modification of the gut microbiota by specific nutrients. Indeed, the
decrease in bifidobacteria occurring in obese mice fed an HF, sugar-
free diet is counteracted through the administration of nondigestible
oligosaccharides such as inulin-type fructans (ITF). Those compounds
have been considered as prebiotics for year, namely, because they
promote bifidobacteria development in the gut, with beneficial effects
for host [16]. Indeed, we have already shown that, in several models
of diet-induced or genetic obesity [8,10,17], ITF supplementation
counteracts white adipose tissue accumulation and other obesity
related metabolic alterations such as endotoxemia, hepatic insulin
resistance or gut barrier dysfunction. However, the adipose tissue
metabolism in these conditions has been unexplored until now.
The aim of this study was to investigate the impact of gut
microbiota modulation occurring upon ITF supplementation, on
adipose tissue metabolism (lipid storage, adipogenesis and lipolysis)
in a mouse model of diet-induced obesity, and to relate those effects
with the changes in gut microbiota composition (prebiotic effect). We
focused on the influence of ITF on GPR43 expression and related
adipose tissue targets implicated in adipocyte differentiation:
peroxisome proliferator activated receptor gamma (PPARγ), CCAAT-
enhancer-binding protein α (C/EBPα) and adipocyte-specific genes
such as the adipocyte P2 gene (aP2) [18].
2. Methods and materials
2.1. Animals
Ten-week-old male C57bl6/J mice (Charles River, Brussels, Belgium) were housed
in groups of four mice per cage (eight per group) in a 12-h light/dark cycle (lights off at
6 p.m.) and were given free access to diet and water. The mice were separated into
three groups: the control (CT) group was fed a CT diet (AO4, SAFE, Villemoison-sur-
Orge, France), the HF group received an HF diet (Research Diets, New Brunswick, NJ,
USA) and the HF-ITF groupwas fed the HF diet supplemented with 0.2 g/day permouse
of ITF prebiotics (oligofructose from Orafti, Oreye, Belgium) in water. Mice were
treated during 4 weeks. The HF diet contained 60% lipids (soybean oil and lard), 20%
protein, and 20% carbohydrates as energy content. Food intake, taking into account
spillage, was recorded twice a week. Water consumption was also recorded twice a
week to analyze prebiotic intake.
2.2. Blood and tissue samples
At the end of the experiment, 6-h-fasted mice were anaesthetized by intraperi-
toneal injection of 100 mg/kg of ketamine and 10 mg/kg of xylazine (Anesketin,
Eurovet, Bladel, the Netherlands; Rompun, Bayer Belgium, Sint-Truiden, Belgium).
Retro-orbital blood was collected with haematocrit capillaries in EDTA tubes,
centrifuged (3 min, 13000×g), and plasma was stored at −80°C. The liver was
removed, clamped in liquid N2 and kept at −80°C. Full and empty caecum and fat
tissues (subcutaneous, visceral and epipidymal) were collected, weighed and frozen in
liquid N2. Before freezing the subcutaneous adipose tissue, explants of 20 mg were
collected in order to evaluate the lipolytic activity (see below).
2.3. Gut microbiota analysis
For analysis of the microbial community composition, metagenomic DNA was
extracted from the caecal content of all mice, using the QIAamp DNA stool mini kit
(Qiagen, Venlo, Netherlands) according to the manufacturer's instructions. Denaturing
Gradient Gel Electrophoresis (DGGE) on total bacteria, bifidobacteria, lactobacilli and
the Bacteroides-Prevotella was performed to study the qualitative effect of the
treatment on the structure and composition of the intestinal microbial community.DGGE with a 45–60% denaturant gradient were used to separate the polymerase chain
reaction (PCR) products obtained with a nested approach for the 16S rRNA genes of
bifidobacteria (primers BIF164f-BIF662r) and lactobacilli (SGLAB0158f-SGLAB0667)
[19] and of the Bacteroides-Prevotella cluster (FD1, RbacPre)[20]. The first PCR round
was followed by a second amplification with primers 338F-GC and 518R. The latter
primers were also used to amplify the 16S rDNA of all bacteria on total extracted DNA.
The DGGE patterns obtained were subsequently analysed using the Bionumerics
software version 5.10 (Applied Maths, Sint-Martens-Latem, Belgium). In brief, the
calculation of the similarities was based on the Pearson (product–moment) correlation
coefficient. Clustering analysis was performed using the unweighted pair group
method with arithmetic mean clustering algorithm to calculate the dendrograms of
each DGGE gel and a combination of all gels. The latter was performed on a created
composite dataset. The composite dataset of the 4 DGGE patterns was also used to
perform principal coordinate analysis (PCoA). PCoA ordinations were calculated using
the Pearson product-moment correlation coefficient. Within each character set, this
coefficient subtracts each character from the average value and divides it by the
variance of the character set.
Quantitative PCR (qPCR) was performed to study the quantitative effect of the
treatment on the composition of the intestinal microbial community. qPCR for total
bacteria (using primers PRBA338f and P518r) and specific for bifidobacteria,
lactobacilli or the Eubacterium rectal– Clostridium coccoides cluster were performed
as reported by Possemiers et al. [21]. qPCR for Roseburia spp. was performed as
described before [22], using the primers Ros-F1 and Ros-R1. qPCR for Firmicutes and
Bacteroidetes was performed according to Guo et al. [23], using respectively the
primers Firm934F-Firm1060R and Bact934F-Bact1060R. For the latter three protocols,
the Power SYBR Green PCR Master kit (Applied Biosystems, Foster City) was used. The
qPCR for Bacteroides-Prevotella spp. was performed as described by Rinttilä et al. [24],
using the qPCR Core kit for SYBR Green I (Eurogentec, Seraing, Belgium) and primers
Bacter140f and Bacter140r. All qPCR were performed with an ABI PRISM SDS 7000
Sequence Detection System (Applied Biosystems, Nieuwerkerk a/d Ijssel, the
Netherlands). The statistical analysis was done on logarithmic values.
2.4. Adipose tissue morphometry
The mean adipocytes size was estimated on paraffin-embedded, hematoxylin-
stained, eosin-counterstained sections of subcutaneous tissue. The number of
adipocytes per microscopic field (density) was determined at a magnification of
×100. Total count ranged from 2900 to 5700 cells per condition. The mean surface area
of the adipocytes (μm2) was calculated using image analyzer software (Motic Image
Plus 2.0 ML).
2.5. Lipolytic activity
Fresh explants (20 mg) of subcutaneous adipose tissue (SAT) were incubated with
carbogen during 2 h at 37°C in a Krebs solution [NaCl 118 mM, KCl 4.8 mM, KH2PO4
1.2mM,MgSO4 1.2mM, CaCl2 1.25mM, NaHCO3 25mM, glucose 5mM and 2.5% bovine
serum albumin (BSA) free fatty acid] plus or minus insulin 10nM [25]. After incubation,
tissues were frozen in liquid nitrogen and conserved at−80°C. The incubation medium
was frozen at −20°C until measurement of nonesterified fatty acids (NEFA) by
enzymatic reactions and spectrophotometric detection of reaction end-products
(Randox, United Kingdom). Lipolytic activity is expressed in nanomoles of NEFA
released in the medium per g of adipose tissue after two hours of incubation with or
without insulin [26]. The level of insulin-induced lipolysis inhibition corresponds to
NEFA concentration in presence of insulin minus NEFA released in basal conditions.
2.6. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and immunoblotting
Frozen explants of SAT incubated for evaluating the lipolytic activity were
homogenized in radioimmunoprecipitation assay (RIPA) buffer [25 mM Tris-HCl, 150
mM NaCl, 0.1% SDS, 1% Tergitol type NP-40, 1% sodium deoxycholate, a phosphatase
inhibitor cocktail and a protease inhibitor cocktail]. The homogenates were then
centrifuged for 20 min at 13,000×g and the supernatant was removed. This step was
repeated three times. Supernatants were combined with Laemmli sample buffer and
separated by SDS-PAGE. After electrophoretic separation at 40 mA, the proteins were
transferred to a polyvinylidene fluoride (PVDF) membrane at 80 V for 2 h, followed
by western blot analysis. Membranes were then incubated in a 5% Blotto solution.
Subsequently, membranes were incubated overnight at 4°C with an anti-phospho-
Akt (Ser 473, Cell Signaling) diluted (1:1000) in Tris-buffered saline Tween-20
(TBST) containing 1% BSA. Membranes were washed in TBST and incubated for 1
h at room temperature in a secondary antibody conjugated to horseradish
peroxidase (1:10,000; Sigma, St. Louis, MO, USA). After additional washes,
chemiluminescence detection was carried out using an Enhanced Chemiluminescent
Western blotting kit (ECL Plus, Amersham Biosciences) and hyperfilms (Hyperfilm
ECL, Amersham Biosciences). Then, the membranes were stripped and re-probed
with an antibody recognizing the total form of Akt (Cell Signaling) to which all data
were reported. The films were scanned with an ImageScanner using the Labscan
software and quantified with the Image Master 1D Image Analysis Software
(Amersham Biosciences).
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Homeostasis Model Assessment (HOMA) was calculated as follows: [fasted
glycemia (mM) ⁎fasted insulinemia (μU/ml)]⁎22.5. Fasted glycemia was determined
by enzymatic reactions and spectrophotometric detection of reaction end-products
(Glucose PAP, Elitech Diagnostics). Plasma insulin concentration was determined in 5
μl of plasma using an ELISA kit (Mercodia, Upssala, Sweden), following the
manufacturer's instructions.
2.8. Real-time quantitative PCR
Total RNA was isolated from subcutaneous adipose tissue using the TriPure
isolation reagent kit (Roche Diagnostics Belgium, Vilvoorde). cDNA was prepared by
reverse transcription of 1 mg total RNA using the Kit Reverse transcription System
(Promega, Leiden, The Netherlands). Real-time PCR were performed with the StepOne
Plus real-time PCR system and software (Applied Biosystems, Den Ijssel, The
Netherlands) using SYBR-Green (Applied Biosystems) for detection. Ribosomal protein
L19 (RPL19) RNA was chosen as housekeeping gene. The targeted mouse genes are
detailed in Table 1. All samples were run in duplicate in a single 96-well reaction plate
and data were analyzed according to the 2−ΔCT method. The identity and purity of the
amplified product was checked through analysis of the melting curve carried out at the
end of amplification.
2.9. Fatty acid profile analysis in adipose tissue
To determine the fatty acid profile in subcutaneous adipose tissue, 20 mg of tissue
were homogenized in 3 ml of 2:1 chloroform:methanol. Homogenates were filtrated,
and filters were rinsed with methanol and chloroform. Samples were centrifuged after
addition of KCl 0.88%, the upper phase was removed and KCl 0.88%:MeOH (1:1) was
added before a second centrifugation. The chloroform phase was evaporated under
nitrogen flux. Fatty acids were methylated in a solution of KOH inmethanol (0.1 mol/L)
at 70°C for 60 min, then in a solution of HCl in methanol (1.2 mol/L) at 70°C for 20 min,
and finally extracted with hexane. Fatty acid methyl esters (FAME) were quantified by
a gas–liquid chromatograph (GC Trace ThermoQuest, Thermo-Finnigan, Milan, Italy)
equipped with a flame ionization detector, automatic injector and a fused silica
capillary column (100 m, 25.20 mm i.d.) coated with a film of biscyanopropyl
polysiloxane (RT-2560; Restek, Interscience, Belgium) using H2 as the carrier gas
operated at a constant pressure of 200 kPa. Injection was on column in order to inject
the entire sample into the column head. The initial oven temperature was 80°C,
increased at 25°C/min to 175°C (held for 25 min), then increased at 10°C/min to 205°C
(held for 4 min), then increased at 10°C/min to 225°C (held for 20 min) and finally
decreased at 20°C/min to 80°C. The temperature of the flame ionisation detector was
maintained at 255°C. Hydrogen flow to the detector was 35 ml/min, and airflow was
350 ml/min. Each peak was identified and quantified by comparison of retention times
with pure FAME standards (Alltech Associates, Deerfield, IL, USA; except CLA isomers
from Nu-Chek Prep, Elysian, MN, USA). Each FA was expressed as a percentage of FAME
reported (identified).
2.10. Adipose tissue explants culture
Subcutaneous adipose depots of 20 ten-week-old male C57bl6/J mice were
precisely dissected; all visible vessels, particles, and conjunctive tissue were removed.
Fat tissue was cut with scissors into small pieces (4 mm3) pooled and placed in Krebs
buffer, pH 7.4, containing 2% (w/v) free fatty acid–BSA and penicillin (100 IU/ml),
streptomycin (100 μg/ml), amphotericin B (2.5 μl/ml) (Invitrogen); 250 mg of adipose
tissue were rinsed in phosphate-buffered saline and incubated in 100-mm petri dishes
containing 10 ml MEM with Earle's salts (Invitrogen) supplemented with 0.5% free
fatty acid-BSA, penicillin (100 IU/ml), streptomycin (100 μg/ml), amphotericin B (2.5
μl/ml) (Invitrogen) and then cultured. All conditions were carried out in three different
dishes (n=3). The dishes were cultured for 24 h at 37°C in a 5% CO2 atmosphere. The
basal concentration of glucose in fresh mediumwas 5 mmol/L and those of cortisol and
insulin were extremely low (≈0.5 nmol/L and 3 pmol/L, respectively). DifferentTable 1
Sequences for the primers used in real-time quantitative PCR
GenBank accession no. Forward
RPL19 NM_009078.1 GAAGGT
GPR43 NM_146187.3 TTCTTAC
PPARγ NM_011146.2 CTGCTC
aP2 NM_024406.1 GATGCC
C/EBPα NM_007678.3 GAGCCG
LPL NM_008509.2 TCTGTA
CD36 NM_007643.3 GCCAAG
TLR-4 NM_021297.2 GCAGAA
F4/80 NM_010130.2 TGACAA
CD36, cluster of differentiation 36; TLR-4, toll like receptor 4.pharmacological agents were used in various combinations in accordance with the
experimental protocols. Troglitazone (10 μM) (Sigma) and GW9662 (10 μM) (Sigma)
were diluted in DMSO which served as CT condition. Cell viability did not change over
the course of culture (not shown). At the end of the experiment, the adipose material
was rinsed in phosphate-buffered saline, collected, immediately frozen in liquid
nitrogen, and stored at −80°C until subsequent mRNA analysis.
2.11. Chronic load with lipopolysaccharides (LPS)
Ten-week-old male C57bl6/J mice (Charles River, Brussels, Belgium) were
housed in a controlled environment in a 12-h light/dark cycle (lights off at 6:00 pm)
and were given free access to diet and water. Mice were implanted subcutaneously
with an osmotic minipump (Alzet Model 2004; Alza, Palo Alto, CA, USA) as
previously described [27]. The pumps were filled either with Tween 0.1%/saline or
LPS (from Escherichia coli 055:B5; Sigma) to infuse 300 μg/kg/day for 4 weeks. At the
end of the experiment, 6-h-fasted mice were anaesthetized as described supra. Fat
tissues (subcutaneous, visceral and epipidymal) were collected, weighed and frozen
in liquid N2.
2.12. Acute load with LPS
Ten-week-old male C57bl6/J mice (Charles River, Brussels, Belgium) were housed
in groups of three mice per cage (six per group) in a 12-h light/dark cycle (lights off at
6:00 pm) and were given free access to diet (AO4, SAFE, Villemoison-sur-Orge, France)
and water for acclimatizing. After 2 h of fasting, mice were intraperitoneally injected
either with saline solution (CT group) or with LPS (5 mg/kg, from Escherichia coli 055:
B5; Sigma) (LPS group). Four hours after injection, mice were anaesthetized as
described supra. Vena cava blood was collected in EDTA tubes, centrifuged (3 min,
13000×g) and plasma was stored at−80°C. Fat tissues (subcutaneous and epipidymal)
were collected, weighed and frozen in liquid N2.
All mice experiments were approved by the local committee and the housing
conditions were as specified by the Belgian Law of November 14, 1993 on the
protection of laboratory animals (agreement no. LA 1230314) in accordance with the
declaration of Helsinki.
2.13. Statistical analysis
Results are presented as mean±S.E.M. Statistical significance of difference
between groups was assessed either by one-way analysis of variance (ANOVA)
followed by post hoc Tukey's multiple comparison tests when comparing three groups
or more, or by a Student's t test when comparing 2 groups (Graph-Pad Prism Software,
San Diego, CA, USA; www.graphpad.com). Data with different superscript letters are
significantly different (Pb.05) according to the post hoc ANOVA statistical analysis.
⁎Significantly different from the CT group (Pb.05, Student's t test).
3. Results
3.1. ITF promote selective changes in caecal microbial composition
The weight of the caecal content is considered as a measure for the
extent of bacterial fermentation and changes in this weight are
therefore related with changes in the microbial activity or composi-
tion in the caecum. As compared to the CT diet, administration of the
HF diet induced a significant decrease in the caecal content, an effect
which was however counteracted by the co-administration of
prebiotics with the HF diet (CT: 0.268±0.018a; HF: 0.114±0.015b;
HF-ITF: 0.246±0.025a g). Changes were also observed in the bacterial
counts as quantified by qPCR (Fig. 1A). Administration of the HF diet
induced a decrease in total bacterial counts and in the counts of mostprimer (5′ to 3′) Reverse primer (5′ to 3′)
CAAAGGGAATGTGTTCA CCTTGTCTGCCTTCAGCTTGT
TGGGCTCCCTGCC TACCAGCGGAAGTTGGATGC
AAGTATGGTGTCCATGA TGAGATGAGGACTCCATCTTTATTCA
TTTGTGGGAACCTG GCCATGCCTGCCACTTTC
AGATAAAGCCAAACA GCGCAGGCGGTCATTG
CGGCACAGTGG CCTCTCGATGACGAAGC
CTATTGCGACATGA ATCTCAATGTCCGAGACTTTTCAAC
AATGCCAGGATGATG AACTACCTCTATGCAGGGATTCAAG
CCAGACGGCTTGTG CAGGCGAGGAAAAGATAGTGT
Fig. 1. (A) Gut microbiota analysis in ceacal content of mice fed a CT diet, an HF diet or an HF-ITF diet after 4 weeks of treatment. Data are mean±S.E.M. Data with different superscript
letters are significantly different at Pb.05, according to the post hoc ANOVA statistical analysis. (B) PCoA was used to explore the similarity within a composite dataset consisting of
DGGE fingerprints of total bacteria, bifidobacteria, lactobacilli and the Bacteroides-Prevotella cluster. The DGGE analysis was performed on the cecum content of mice (n=8/group) fed
a CT diet (black symbols), an HF diet (grey symbols) or an HF-ITF diet (white symbols) during 4 weeks.
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Fig. 2. Metabolic and histological analysis of subcutaneous adipose tissue in mice fed a CT diet, an HF diet or an HF-ITF diet after 4 weeks of treatment. (A) Subcutaneous adipose tissue
mass. (B) Mean adipocytes size. (C) Histological pictures in hematoxylin and eosin stain (bar=100 μm). (D) Free fatty acids (FFA) released by explants of SAT after 2 h of incubation
with or without insulin. (E) Percent of insulin-induced Akt phosphorylation reported to CT group. (F) Homeostasis model assessment. Data are mean±S.E.M. Data with different
superscript letters are significantly different at Pb.05, according to the post hoc ANOVA statistical analysis. The Two-way ANOVA analysis of Panel D shows a significant effect of insulin
and treatment (Pb.05); ⁎Pb.05 “basal lipolysis” versus “insulin-inhibited lipolysis” according to Bonferroni posttest.
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expected, the co-administration of the HF diet with ITF significantly
increased bifidobacterial counts by 100-fold. However, ITF treatment
also led to a drop in Roseburia spp. and of Clostridium cluster XIVa.
Changes in the bacterial composition were also assessed with
DGGE fingerprinting analysis of different bacterial groups. The
combination of all different fingerprints, followed by similarity
analysis using PCoA, indeed confirmed that the composition of the
microbial community was strongly affected by the type of diet which
was administered to the animals (Fig. 1B). A representative DGGE gel
for general bacteria is shown in supplemental data (SD 1).3.2. ITF prebiotics lessen fat mass development driven by the HF diet
Energy intake was monitored twice a week during the treatment.
Total energy consumption, calculated upon diet's energy content and
prebiotic supplementation in water, tended to increase in HF-fed
mice andwas notmodified by ITF treatment (CT: 11.15, HF: 15.07, HF-
ITF: 13.79 kcal/day per mouse). Fat ingestion was strongly increased
in HF fedmice versus CT, and prebiotics did notmodify this parameter
in a significant way (CT: 0.101; HF: 1.725; HF-ITF: 1.579 g fat/day per
mouse). Moreover, ITF prebiotics blunted the HF diet-induced bodyweight gain (CT: 2.29±0.21; HF: 8.08±0.86; HF-ITF: 4.57±0.55 g)
and subcutaneous adipose tissue accumulation (Fig. 2A), despite the
similar fat ingestion.3.3. ITF prebiotics increase basal lipolysis and improve adipose tissue
insulin response
Mean adipocyte size in SATwas significantly increased inHF-fedmice
versus CT, whereas ITF treatment normalized this parameter (Fig. 2B and
2C). In this tissue, basal lipolysis— estimated through the release of free
fatty acids in themedium—wasdecreased by theHFdiet and restored by
the supplementation with ITF (Fig. 2D). Similar results were obtained
when glycerol was measured in the culture medium as an index of
lipolysis (data not shown). Moreover, lipolysis inhibition by insulin was
lower inexplantsof SAT fromHF-fedmice incomparison toexplants from
CT mice and ITF restored insulin effect to the level of CT group (Fig. 2D).
The insulin-induced Akt phosphorylation, which reflects the response to
insulin, tended to decrease in explants of SAT of HF-fed mice versus CT
animals and was partially restored in ITF-treated mice (Fig. 2E). In
accordancewith this result, the HF diet-induced an important increase of
insulin resistance index (HOMA) value and this was counteracted by the
addition of ITF (Fig. 2F).
Fig. 3. Expression of genes involved in subcutaneous adipose tissue metabolism in mice fed a CT diet, an HF diet or an HF-ITF diet after 4 weeks of treatment. (A) Expression of GPR43. (B) Expression of aP2, CEBPα and PPARγ, three
adipocyte differentiation markers. (C) Expression of CD36 and LPL, two target genes of PPARγ activation. (D) Correlations between GPR43, adipocytes differentiation markers and adipocytes size. The CT group is set at 1 value. See Table 1
for primer sequences and abbreviations. Data are mean±S.E.M. Data with different superscript letters are significantly different at Pb.05, according to the post hoc ANOVA statistical analysis.
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related gene expression occurring in the subcutaneous adipose tissue of
HF-fed mice
Since GPR43 is implicated in both lipolysis regulation and
adipocyte differentiation [14,15], the expression of this receptor
was measured and its variation was correlated with key factors
controlling adipocyte differentiation. The HF diet increased GPR43
mRNA fivefold and this effect was blunted by ITF (Fig. 3A). The HF
treatment also significantly increased aP2 mRNA content in the
subcutaneous adipose tissue, while the HF-ITF group showed an
expression similar to the CT group. The same profile was observed for
C/EBPα mRNA. Surprisingly, PPARγ expression was not modified by
HF diet but ITF tended to decrease its expression in comparison to HF
group (Fig. 3B). Target genes of PPARγ, namely CD36 and LPL mRNA,Fig. 4. Fatty acid profile in subcutaneous adipose tissue of mice fed a CT diet, an HF diet or a
identified fatty acid. Data are mean±S.E.M. Data with different superscript letters are significwere increased in HF fed mice and the addition of ITF counteracted
this effect (Fig. 3C). Finally, GPR43 expression was positively and
significantly correlated to aP2, C/EBPα and PPARγmRNAs but also to
adipocytes size (Fig. 3D).
3.5. ITF prebiotics do not influence the changes in fatty acid profile
occurring in subcutaneous adipose tissue of HF-fed mice
Dietary lipids have an impact on the fatty acid profile in adipose
tissue [28,29]. Moreover, it has been clearly demonstrated that a
number of fatty acids, especially polyunsaturated fatty acids (PUFAs),
can bind and activate PPARγ at micromolar concentrations [30,31].
Therefore, the fatty acid patternwas analyzed in SAT ofmice fed theHF
diet plus or minus prebiotics. Fig. 4 shows the SAT levels of fatty acids
present in the HF diet and/or able to activate PPARγ. Some of themn HF-ITF diet after 4 weeks of treatment. Results are expressed as percentage of total
antly different at Pb.05, according to the post hoc ANOVA statistical analysis.
Fig. 5. Expression of GPR43 and aP2 in explants of subcutaneous adipose tissue incubated in a control medium (CT) or with different pharmacological agents: a PPARγ agonist (TZD), a
PPARγ antagonist (GW9662) or a combination of both during 24 hours. The CT group is set at 1 value. See Table 1 for primer sequences and abbreviations. Data are mean±SEM. Data
with different superscript letters are significantly different at Pb.05, according to the post hoc ANOVA statistical analysis.
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and α-linolenic acid, two potent PPARγ activators, were increased by
the HF diet. The coadministration of ITF did not modify the HF diet-
induced fatty acid pattern. The slight but significant decrease of α-
linolenic acid observed upon prebiotic feeding was not significantFig. 6. (A) Expression of TLR-4 and F4/80 in subcutaneous adipose tissue of mice fed a CT diet, a
in subcutaneous adipose tissue of mice receiving LPS chronically via osmotic minipump duri
injected with saline solution (CT) or with LPS and killed 4 hours after injection. The CT group is
Data with different superscript letters are significantly different at Pb.05, according to the poanymore when results were expressed in μg/mg tissue (data not
shown). It is important to note that the fatty acids profile in SATdid not
fit with the composition of the diets except for stearic, oleic and α-
linolenic acids that were both increased in HF diet and in adipose
tissue of HF fed mice (Supplemental data 2).n HF diet or an HF-ITF diet after 4 weeks of treatment. (B) Expression of GPR43 and aP2
ng 4 weeks. (C) Expression of GPR43 and aP2 in subcutaneous adipose tissue of mice
set at 1 value. See Table 1 for primer sequences and abbreviations. Data are mean±SEM.
st hoc ANOVA statistical analysis.
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occurring in SAT upon HF and prebiotics treatment
As shown in our HF study, a modulation of PPARγ activity could
have an impact on GPR43 expression. Based on an ex vivo experiment,
we found that a PPARγ agonist (thiazolidinedione; TZD) significantly
increased GPR43 mRNA level as compared to the CT conditions. This
effect was abolished when SAT explants were incubated in the
presence of a PPARγ antagonist (GW9662). Similar results were
observed for aP2 mRNA (Fig. 5).
3.7. LPS is not directly involved in the modulation of GPR43 expression
in SAT
HF diets have been shown to promote obesity and insulin
resistance, namely by favoring LPS translocation from the gut, a
phenomenon negatively controlled by prebiotics [7,8]. In the present
experiment, we confirmed that the HF diet increased the expression
of TLR4 and F4/80 in SAT and that this was counteracted by the
supplementation with ITF (Fig. 6A). In order to study the potential
impact of LPS on GPR43 and related-adipocyte differentiation gene
expression, we used two models of LPS-induced inflammation. In
mice chronically infused during 1 month with low doses of LPS —
mimicking endotoxemia which occurs upon HF feeding — no
modification in GPR43 and aP2 expression in SAT was observed as
compared to the CT group (Fig. 6B). In mice receiving an acute load of
LPS (ip) and killed 4 h after the single injection, again, nomodification
of GPR43 and aP2 mRNA in SAT was detected (Fig. 6C).
4. Discussion
Obesity is characterized by an excess of fat mass and has been
associated to an altered gut microbiota composition [1,2]. In this
context, prebiotics such as ITF are considered as a nutritional tool to
promote bacterial fermentation, to induce qualitative changes of gut
microbiota and, thereby, to counteract fat mass development and
relatedmetabolic disorders [8,10,17]. In our study, we showed that an
HF diet — which also contains digestible carbohydrates — led to
changes in gut microbial composition that differ from the ones
observed when mice were fed a HF/low-carbohydrate diet [8]. The HF
diet used in our study led to a drop in total bacterial counts and in the
counts of most of the analyzed bacterial groups, except for
bifidobacteria. As expected, an important increase in bifidobacteria
level occurred upon the coadministration of the HF diet and ITF. This
confirms the classical prebiotic effect of ITF in this model of diet-
induced obesity. However, ITF in this model also led to a decrease of
both Roseburia spp and the counts of Clostridium cluster XIVa, a fact
that is more surprising, since Roseburia is involved in “metabolic”
cooperation with bifidobacteria for the use of fructans as metabolic
substrates [32]. As previously described, ITF prebiotics counteracted
the HF diet-induced body weight gain and fat mass accumulation in
our conditions. We also confirmed that, in HF and HF-ITF groups, a
negative correlation was observed between fat mass and bifidobac-
teria. Moreover, we found here a positive correlation between fat
mass and Clostridium clusters XIVa, whereas no correlation was found
for Roseburia spp. (Supplemental data 3).
We focused our metabolic studies on the SAT because it is a
homogenous tissue which is metabolically active, and because its
weight is decreased by prebiotics in most studies reporting this
parameter [8,10,27,33,34]. Histological pictures of SAT explants
show that the adipocytes were larger upon the HF treatment and
got smaller when the HF diet was combined with ITF. This was
further confirmed by the determination of the adipocytes surface
which was significantly increased by HF diet, yet counteracted by
ITF. This modulation of adipocytes size could be partly linked tochanges in basal lipolysis, which is decreased in explants of SAT
coming from HF-fed animals and restored to the CT level in ITF
treated animals. Large adipocytes are additionally characterized by
altered insulin sensitivity [35,36]. Our results are in accordance
with this since the insulin-induced phosphorylation of Akt tended
to decrease in explants of SAT upon HF diet and was partially
restored in the presence of ITF. The inhibition of lipolysis by insulin
was indeed diminished upon HF feeding whereas the ITF restored
the response to insulin in the SAT explants. This is in agreement
with the impaired insulin sensitivity in HF-fed animals and the
restoration by ITF. Finally, the insulin sensitivity index, HOMA,
confirmed that ITF-prebiotics could counteract the HF diet-induced
insulin resistance. Therefore, if an increased basal lipolysis can be
evoked to explain a lower fat mass development upon the prebiotic
treatment, the higher adipose tissue insulin sensitivity could
counteract this effect in the postprandial state.
It has been demonstrated that the activation of GPR43 in the
adipose tissue by SCFA drives the inhibition of lipolysis [15] and
stimulate adipocyte differentiation [14]. In order to test the potential
implication of GPR43 in the modulation of adipose tissue metabolism
by prebiotics in HF-fed animals, we measured GPR43 expression in
the SAT. The HF diet indeed led to a strong increase in GPR43 mRNA
levels, thereby confirming the data published by Hong et al. [14].
Interestingly, the ITF-prebiotics completely blunted the effect of the
HF diet on GPR43 expression. This could not be explained by changes
in total fat intake, which was not modified by prebiotic treatment.
To test the effect of prebiotics on adipocyte differentiation, genes
involved in this process have been analyzed in our model. aP2 and C/
EBPαmRNAswere increased by the HF diet and restored to basal level
by ITF. This was correlated with the observed changes in GPR43
expression. Unexpectedly, PPARγ expression was not modified in the
same way as these two markers of adipogenesis even though this
receptor is known to be a master regulator of this process [37].
Therefore, we postulated that the increased adipocyte differentiation
in HF-fed mice was not related to a modification of PPARγ expression
but rather to a modulation of its activation. To test this hypothesis, we
measured expression of genes well known to be up-regulated by
PPARγ agonists, as markers for PPARγ activation, namely CD36 and
LPL [38,39]. As expected, CD36 and LPL mRNAs were significantly
increased by the HF diet and ITF down-regulated their expression.
Moreover, as these two genes are implicated in lipid accumulation in
adipocytes, the changes in the expression of GPR43 and PPARγ-
activated genes are in accordance with the decrease in fat mass
development by ITF-prebiotics in HF-fed animals. In addition, even if
PPARγ expression was not significantly modified by dietary treat-
ments, we highlighted a positive correlation between this parameter
and GPR43 expression and this supports the hypothesis of a link
between PPARγ and GPR43.
Several fatty acids, especially PUFAs, can bind and activate
PPARγ at micromolar concentrations [30,31]. To determine whether
some fatty acids present in the SAT and coming from the HF diet
could induce the PPARγ activation and so the over-expression of
PPARγ target genes, the fatty acid pattern was analysed in SAT. Two
well known PPARγ activators, namely oleic acid and α-linolenic
acid, were significantly increased in SAT of HF fed mice thus
supporting our hypothesis. However, the coadministration of ITF
did not modify this fatty acid pattern and so did not allow
explaining the inhibition of HF diet-induced PPARγ activation and
over-expression of PPARγ target genes upon ITF. Nevertheless, we
may not be sure that those fatty acids are present in a sufficient
concentration within the nuclei to activate PPARγ and that could
maybe explain the lack of effect of ITF treatment.
At that stage, we did not know yet whether the increase in GPR43
expression upon the HF diet and the counteracting effect of ITF-
prebiotics preceded or followed modulation of PPARγ activity. To
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explants ex vivo with a PPARγ agonist (TZD) and/or a PPARγ
antagonist (GW9662). The PPARγ agonist increased GPR43 expres-
sion in this adipose tissuemodel, as previously suggested in adipocyte
cell model (3T3-L1) [14]. Moreover, the PPARγ antagonist blunted the
expression of GPR43 in adipose tissue explants suggesting that
compounds that exert an antagonist effect on PPARγ could be
implicated in the modulation of GPR43 expression upon the prebiotic
treatment. The same profile was observed for aP2 expression. In view
of these results and the positive correlations highlighted between
GPR43 and differentiation-related genes, we can propose a link
between this G protein-coupled receptor and PPARγ activation.
Moreover, we found in literature that the modulation of PPARγ
activity by PPARγ agonists or antagonists had an impact on
adipocytes size [40–42]. Therefore, the link between the three events
(PPARγ activation, adipocytes size and GPR43) seems relevant.
One question however remained: could LPS be involved in GPR43
expression changes upon HF and ITF treatments? We have previously
shown that an HF diet increases the serum levels of LPS, that this
increase is involved in fat mass development, and that this effect may
be counteracted by ITF-prebiotics [7,8]. Indeed, the fact that both TLR4
and F4/80 expression were increased in the SAT of HF-fed mice and
that this effect was counteracted by ITF administration is a
confirmation of the likely involvement of LPS in adipose tissue
metabolism. To investigate whether LPS could be a driver of GPR43
modulation in the adipose tissue, two experimental protocols were
designed to study the impact of LPS on GPR43 and adipocyte
differentiation genes expression. In a first experiment, mice were
submitted to a chronic load of LPS administered via an osmotic
minipump during 4 weeks. The chronic treatment with LPS, however,
did not modify GPR43 mRNA or the expression of the adipocyte
differentiation marker, aP2, in SAT. Next, mice were submitted to an
acute load of LPS and killed 4 hours after the intra-peritoneal
injection. Similarly to the chronic LPS treatment, LPS had no impact on
the expression of GPR43 and aP2.We also measured the expression of
other PPARγ-activated genes (CD36 and LPL) and they were not
modified by an acute load of LPS (data not shown). All these results
counteract the hypothesis of a key role of LPS in the modulation of
GPR43 expression occurring upon the HF treatment.
In conclusion, the HF diet used in our study induced important
changes in adipose tissue metabolism including an increase in
adipogenesis (overexpression of differentiation-related genes like
aP2 and C/EBPα but also over-expression of genes implicated in lipid
storage such as CD36 and LPL), a decrease in basal lipolysis and a
lower response to insulin in explants of SAT. These effects seemed
related to an activation of PPARγ, as shown by the overexpression of
PPARγ target genes. Moreover, PPARγ activation could be a driver of
the important increase of GPR43 expression upon HF feeding whereas
LPS did not seem to be implicated in this effect. Interestingly, the
administration of ITF-prebiotics to HF-fed mice led to an important
increase of bifidobacteria levels and counteracted all the HF diet-
induced alterations, including a restoration to the CT level of PPARγ
activity and GPR43 expression. The specific modulation of the gut
microbiota by prebiotics is an interesting tool to modulate adipose
tissue metabolism which is altered in obesity. However, we do not
know yet how ITF-prebiotics counteract HF diet-induced PPARγ
activation. A specific study could be devoted to the mechanism by
which ITF blunt PPARγ activation, in order to propose this nutritional
approach in the management of fat mass development and obesity.
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article Supplemental data 1. General bacteria DGGE gel (Pearson
Correlation) performed on the cecum content of mice (n=8/group)
fed a CT diet (Symbols 1–8), an HF diet (HF, Symbols 9–16) or an HF-
ITF diet (Symbols 17–24) during 4 weeks.Supplemental data 2. Fatty
acid composition of the two diets: the AO4 diet or CT diet and the HFdiet. Results are expressed in g FA/kg diet. Supplemental data 3.
Correlations between fat mass and bifidobacteria (A), Clostridium
cluster XIVa (B) and Roseburia spp. (C) inmice fed a CT diet, an HF diet
or an HF-ITF diet after 4 weeks of treatment.
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